Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epacadostat + Ipilimumab in Unresectable or Metastatic Melanoma
NCT01604889Phase 2Terminated
- Sponsor
- Incyte
- Start
- Mar 2012
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epacadostat in melanoma, sponsored by Incyte. Started Mar 2012; status: terminated.
02
Drugs
epacadostat
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01604889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01604889.